Patients
65 % of 1-year-olds
DTP3 vaccine, DR Congo, 2025 (WHO).
Compare every country on the Public Health DashboardDR Congo Measles Public Health Report: Disease Burden, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook
Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.
| Topic | Measles |
|---|---|
| Place | DR Congo |
| DTP3 vaccine (latest) | 65% of 1-year-olds (2025)Source: WHO Global Health Observatory, DTP3 vaccine (% of 1-year-olds). Retrieved 22 Nov 2026. |
| Report sections | 16 (table of contents) |
| Formats | PDF, PPTX, XLSX |
Measles is a highly contagious viral disease that can cause pneumonia, blindness and death, and it is usually the first disease to return when vaccination drops. This report covers measles cases, measles outbreaks and measles complications.
The report sets out the prevalence, incidence and, where relevant, deaths from measles in DR Congo, and the overall burden, using DTP3 Coverage, Measles Second-Dose Coverage, Zero-Dose Children, Vaccine-Preventable Disease Cases and Dropout Between Doses.
The burden is broken down by age (infants under 1 year, children 1–4 years, children 5–14 years, adolescents 15–19 years and adults), gender and income, with a focus on zero-dose children, children in urban slums, children in conflict areas, remote rural communities, pregnant women and older adults.
Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.
Main risk factors include distance to health services, conflict and insecurity, vaccine hesitancy and misinformation, poverty and low maternal education, weak supply chains and health worker shortages. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.
The report reviews how aware people are of measles and how far screening reaches them, through vaccination registers and home-based records, disease surveillance, coverage surveys and tracing missed children, by group and by area.
It compares the number of people diagnosed with the estimated number affected, to show the undiagnosed burden and how many people are lost between screening and treatment.
Treatment and prevention covered include two-dose measles vaccination, outbreak response campaigns, vitamin a for cases and case-based surveillance, with how many people receive treatment and how many stay on it.
Long-term effects covered include outbreaks of vaccine-preventable disease, child deaths, disability from preventable disease and strain on health services, along with other conditions that often occur alongside measles.
The report looks at immunisation clinics and outreach posts, cold chain equipment, vaccinators and community mobilisers and vaccine supply chains, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.
DR Congo scores 41 out of 100 on the WHO universal health coverage index (2023).[1] People pay 38.0% of all health spending out of their own pockets (2023).[2] Money from abroad pays for 37.0% of health spending (2023).[3] DTP3 vaccine: 65% of 1-year-olds in 2025, the latest WHO figure for DR Congo.[4]
[1] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 22 Nov 2026.
[2] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 22 Nov 2026.
[3] World Bank Open Data, Health spending from abroad (% of health spending). Retrieved 21 Nov 2026.
[4] WHO Global Health Observatory, DTP3 vaccine (% of 1-year-olds). Retrieved 22 Nov 2026.
It describes the costs of measles to health systems and households, including out-of-pocket spending and lost productivity, and how government, donors and NGOs fund the response.
Worldwide guidance and funding for measles include WHO Immunization Agenda 2030, Gavi, the Vaccine Alliance, UNICEF Supply Division and Global Polio Eradication Initiative. The report reviews national programmes, donor and NGO funding, and what is known about their impact.
Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.
The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.
It looks ahead at the likely future burden of measles, the healthcare it will need and the areas most vulnerable.
The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), Demographic and Health Surveys (DHS), WHO Vaccine-Preventable Disease Surveillance and National Immunisation Programme Data. Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.
What doctors and scientists are doing in Measles Public Health Report right now, from free public sources.
65 % of 1-year-olds
DTP3 vaccine, DR Congo, 2025 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 22 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, DTP3 vaccine (% of 1-year-olds). Retrieved 22 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 22 Nov 2026.
From our blog
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
DR Congo · 6 shared keywords
Pharmaceuticals · Global
Pharmaceuticals · Global
Healthcare Services · Global
Pharmaceuticals · Global
Pharmaceuticals · Global
Pharmaceuticals · Global